298 related articles for article (PubMed ID: 27852260)
1. Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic.
Athanazio R; Carvalho-Pinto R; Fernandes FL; Rached S; Rabe K; Cukier A; Stelmach R
BMC Pulm Med; 2016 Nov; 16(1):153. PubMed ID: 27852260
[TBL] [Abstract][Full Text] [Related]
2. Real-life effectiveness of budesonide/formoterol therapy in asthma: A subanalysis of the SMARTASIA study.
Lin J; Tang Y; Xiu Q; Kang J; Cai S; Huang K; Itoh Y; Ling X; Zhong N
Allergy Asthma Proc; 2016; 37(1):27-34. PubMed ID: 26831844
[TBL] [Abstract][Full Text] [Related]
3. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting.
Søes-Petersen U; Kava T; Dahle R; Lei Y; Dam N
Clin Respir J; 2011 Jul; 5(3):173-82. PubMed ID: 21679353
[TBL] [Abstract][Full Text] [Related]
4. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
[TBL] [Abstract][Full Text] [Related]
5. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study.
van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R
Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455
[TBL] [Abstract][Full Text] [Related]
6. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
[TBL] [Abstract][Full Text] [Related]
7. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[TBL] [Abstract][Full Text] [Related]
8. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
Aubier M; Haughney J; Selroos O; van Schayck OC; Ekström T; Ostinelli J; Buhl R
Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
[TBL] [Abstract][Full Text] [Related]
9. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
Chervinsky P; Baker J; Bensch G; Parasuraman B; Boggs R; Martin P; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
[TBL] [Abstract][Full Text] [Related]
12. Overall asthma control: the relationship between current control and future risk.
Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.
Price DB; Williams AE; Yoxall S
Respir Res; 2007 Jul; 8(1):46. PubMed ID: 17610727
[TBL] [Abstract][Full Text] [Related]
14. ["Real-life"-data on asthma control using budesonide/formoterol for both maintenance and relief: the Swiss experience].
Steurer-Stey C; Courteheuse C; Taegtmeyer AB; Leuppi JD
Praxis (Bern 1994); 2009 Nov; 98(23):1335-42. PubMed ID: 19918725
[TBL] [Abstract][Full Text] [Related]
15. The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing.
Buhl R; Kardos P; Richter K; Meyer-Sabellek W; Brüggenjürgen B; Willich SN; Vogelmeier C
Curr Med Res Opin; 2004 Aug; 20(8):1209-20. PubMed ID: 15324523
[TBL] [Abstract][Full Text] [Related]
16. Daily versus as-needed corticosteroids for mild persistent asthma.
Boushey HA; Sorkness CA; King TS; Sullivan SD; Fahy JV; Lazarus SC; Chinchilli VM; Craig TJ; Dimango EA; Deykin A; Fagan JK; Fish JE; Ford JG; Kraft M; Lemanske RF; Leone FT; Martin RJ; Mauger EA; Pesola GR; Peters SP; Rollings NJ; Szefler SJ; Wechsler ME; Israel E;
N Engl J Med; 2005 Apr; 352(15):1519-28. PubMed ID: 15829533
[TBL] [Abstract][Full Text] [Related]
17. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
[TBL] [Abstract][Full Text] [Related]
18. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
[TBL] [Abstract][Full Text] [Related]
19. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
Price D; Haughney J; Lloyd A; Hutchinson J; Plumb J
Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
[TBL] [Abstract][Full Text] [Related]
20. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
